Keep up to date with the latest news from Accelagen
Welcoming our new Business Planning and Analysis Manager
Welcoming our new Business Planning and Analysis Manager Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education,…
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results Local CRO, Accelagen, attracts innovative European drug and antibody developers to trial in Australian marketEngaged by world-renowned European clients and collaborators,…
Accelagen Staff Announcement: Amritha Vangur
Accelagen Staff Announcement: Amritha Vangur The Accelagen family is growing…again!Today we are thrilled to announce that Amritha Vangur has rejoined our team as Clinical Research Associate.Amritha first worked at Accelagen in 2019. The company was in its infancy at the…
Accelagen Staff Announcement: Suzanne Leong
Accelagen Staff Announcement: Suzanne Leong We are excited to formally welcome another highly experienced team member to Accelagen’s fast-growing Australian team, Suzanne Leong.Joining the Accelagen team is Suzanne Leong, the company’s new Senior Clinical Data Manager, bringing with her over…
Accelagen Staff Announcement: Sian Gilmour
Accelagen Staff Announcement: Sian Gilmour One of the things we love most about our work is helping people to learn and develop their careers along whatever path they are inspired to pursue.Today we are excited to share that we have…
Accelagen introduces SureClinical Tools to aid in Clinical Trial Management
Accelagen introduces SureClinical Tools to aid in Clinical Trial Management To help with the efficient management of all our clinical trials, Accelagen has partnered with SureClinical to gain access to their range of electronic trial management tools, commencing with the…
Accelagen facilitates LEDAGA Approval in Australia
Accelagen facilitates LEDAGA Approval in Australia LEDAGA® (Chlormethine hydrochloride) - TGA APPROVAL Accelagen, a Melbourne based Regulatory Affairs, Clinical Research and Development Organisation, are pleased to be an integral part of the approval of LEDAGA® by the Therapeutic Goods Administration…
Accelagen driving development of new candidate for COVID-19 Vaccine
Accelagen driving development of new candidate for COVID-19 Vaccine 1st September 2020 Accelagen is excited to announce the initiation of a new COVID-19 vaccine trial, commencing in Melbourne on Tuesday 1st September! One of the largest vaccine manufacturer’s in the…
Conformity Assessment Application
Conformity Assessment Application Plunkett Consulting has successfully assisted an Australian manufacturer lodge their first Conformity Assessment Application for Class IV in vitro diagnostics (IVD). This submission signifies a successful collaboration for the development of a Device Design dossier to demonstrate…